Your browser doesn't support javascript.
loading
A practical approach for adoption of a hub and spoke model for cell and gene therapies in low- and middle-income countries: framework and case studies.
Saleh, Shadi; Dabbous, Omar; Sullivan, Sean D; Ankleshwaria, Dipen; Trombini, Daiane; Toumi, Mondher; Diaa, Mahmoud; Patel, Anish; Kazazoglu Taylor, Burcu; Tunis, Sean.
Afiliação
  • Saleh S; American University of Beirut, Beirut, Lebanon. ss117@aub.edu.lb.
  • Dabbous O; Novartis Gene Therapies, Inc., Bannockburn, IL, USA.
  • Sullivan SD; CHOICE Institute, School of Pharmacy, University of Washington, Seattle, WA, USA.
  • Ankleshwaria D; Novartis, Dubai, United Arab Emirates.
  • Trombini D; Novartis, Miami, FL, USA.
  • Toumi M; Aix Marseille University, Marseille, France.
  • Diaa M; Novartis, Singapore, Singapore.
  • Patel A; Novartis Gene Therapies, Inc., Bannockburn, IL, USA.
  • Kazazoglu Taylor B; Novartis Gene Therapies, Washington, DC, USA.
  • Tunis S; Rubix Health, Baltimore, MD, USA.
Gene Ther ; 31(1-2): 1-11, 2024 Jan.
Article em En | MEDLINE | ID: mdl-37903929
ABSTRACT
In the rapidly evolving landscape of biotechnologies, cell and gene therapies are being developed and adopted at an unprecedented pace. However, their access and adoption remain limited, particularly in low- and middle-income countries (LMICs). This study aims to address this critical gap by exploring the potential of applying a hub and spoke model for cell and gene therapy delivery in LMICs. We establish the identity and roles of relevant stakeholders, propose a hub and spoke model for cell and gene therapy delivery, and simulate its application in Brazil and the Middle East and North Africa. The development and simulation of this model were informed by a comprehensive review of academic articles, grey literature, relevant websites, and publicly available data sets. The proposed hub and spoke model is expected to expand availability of and access to cell and gene therapy in LMICs and presents a comprehensive framework for the roles of core stakeholders, laying the groundwork for more equitable access to these lifesaving therapies. More research is needed to explore the practical adoption and implications of this model.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Terapia Genética / Países em Desenvolvimento País/Região como assunto: America do sul / Brasil Idioma: En Revista: Gene Ther Assunto da revista: GENETICA MEDICA / TERAPEUTICA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Líbano

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Terapia Genética / Países em Desenvolvimento País/Região como assunto: America do sul / Brasil Idioma: En Revista: Gene Ther Assunto da revista: GENETICA MEDICA / TERAPEUTICA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Líbano